Sign In
Buy FTLF
FitLife Brands Earnings Calls
| Release date | May 14, 2026 |
| EPS estimate | $0.140 |
| EPS actual | $0.170 |
| EPS Surprise | 21.43% |
| Revenue estimate | 24.869M |
| Revenue actual | 25.325M |
| Revenue Surprise | 1.84% |
| Release date | Mar 31, 2026 |
| EPS estimate | $0.250 |
| EPS actual | $0.250 |
| Revenue estimate | 27M |
| Revenue actual | 25.91M |
| Revenue Surprise | -4.04% |
| Release date | Nov 13, 2025 |
| EPS estimate | $0.250 |
| EPS actual | $0.190 |
| EPS Surprise | -24.00% |
| Revenue estimate | 23.875M |
| Revenue actual | 23.485M |
| Revenue Surprise | -1.63% |
| Release date | Aug 14, 2025 |
| EPS estimate | $0.180 |
| EPS actual | $0.180 |
| Revenue estimate | 16.621M |
| Revenue actual | 16.127M |
| Revenue Surprise | -2.97% |
Last 4 Quarters for FitLife Brands
Below you can see how FTLF performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Aug 14, 2025 |
| Price on release | $16.15 |
| EPS estimate | $0.180 |
| EPS actual | $0.180 |
| Date | Price |
|---|---|
| Aug 08, 2025 | $14.52 |
| Aug 11, 2025 | $15.63 |
| Aug 12, 2025 | $16.78 |
| Aug 13, 2025 | $16.22 |
| Aug 14, 2025 | $16.15 |
| Aug 15, 2025 | $16.61 |
| Aug 18, 2025 | $16.75 |
| Aug 19, 2025 | $16.77 |
| Aug 20, 2025 | $16.73 |
| 4 days before | 11.23% |
| 4 days after | 3.59% |
| On release day | 2.85% |
| Change in period | 15.22% |
| Release date | Nov 13, 2025 |
| Price on release | $18.45 |
| EPS estimate | $0.250 |
| EPS actual | $0.190 |
| EPS surprise | -24.00% |
| Date | Price |
|---|---|
| Nov 07, 2025 | $18.36 |
| Nov 10, 2025 | $18.56 |
| Nov 11, 2025 | $19.18 |
| Nov 12, 2025 | $18.97 |
| Nov 13, 2025 | $18.45 |
| Nov 14, 2025 | $18.08 |
| Nov 17, 2025 | $17.60 |
| Nov 18, 2025 | $18.24 |
| Nov 19, 2025 | $18.37 |
| 4 days before | 0.490% |
| 4 days after | -0.461% |
| On release day | -2.01% |
| Change in period | 0.0272% |
| Release date | Mar 31, 2026 |
| Price on release | $14.20 |
| EPS estimate | $0.250 |
| EPS actual | $0.250 |
| Date | Price |
|---|---|
| Mar 25, 2026 | $13.43 |
| Mar 26, 2026 | $13.83 |
| Mar 27, 2026 | $14.28 |
| Mar 30, 2026 | $14.28 |
| Mar 31, 2026 | $14.20 |
| Apr 01, 2026 | $12.10 |
| Apr 02, 2026 | $10.61 |
| Apr 06, 2026 | $10.10 |
| Apr 07, 2026 | $9.80 |
| 4 days before | 5.73% |
| 4 days after | -30.99% |
| On release day | -14.79% |
| Change in period | -27.03% |
| Release date | May 14, 2026 |
| Price on release | $10.24 |
| EPS estimate | $0.140 |
| EPS actual | $0.170 |
| EPS surprise | 21.43% |
| Date | Price |
|---|---|
| May 08, 2026 | $9.55 |
| May 11, 2026 | $9.55 |
| May 12, 2026 | $9.50 |
| May 13, 2026 | $9.53 |
| May 14, 2026 | $10.24 |
| May 15, 2026 | $10.50 |
| May 18, 2026 | $10.82 |
| May 19, 2026 | $10.00 |
| May 20, 2026 | $9.95 |
| 4 days before | 7.23% |
| 4 days after | -2.83% |
| On release day | 2.54% |
| Change in period | 4.19% |
FitLife Brands Earnings Call Transcript Summary of Q1 2026
FitLife Brands Q1 2026 highlights: Total revenue was $25.3M, up 59% year-over-year, driven primarily by the acquisition of Irwin; Legacy FitLife revenue declined ~22% year-over-year. Wholesale grew sharply (to $14.1M, +166% YoY) while online was $11.2M (+6% YoY). Gross margin fell to 37.6% (from 43.1%) largely due to Irwin's lower historical margins, though margins for both Legacy FitLife and Irwin improved sequentially. Contribution rose 42% (driven by Irwin) but Adjusted EBITDA declined 3% to $3.3M and net income fell to $1.7M due to higher amortization and interest from the Irwin acquisition. Irwin: Q1 revenue $12.8M (80% wholesale), growing Amazon sales (roughly $500k in Dec, ~$800k in March, ~$900k in April) and rapid subscriber growth (~500 → ~3,600 by quarter end → >5,700 today). Management cited out-of-stock issues and lost retail accounts as causes of some organic decline at Irwin but expects margins to improve as supply-chain and listing issues are resolved. Balance sheet: paid ~$1.5M term loan amortization (term loan balance $37.6M) and paid down $1.4M on revolver (balance $4.2M), with intent to use excess cash flow to reduce debt further. Operational priorities and catalysts: resolving Irwin out-of-stocks and onboarding ~20 SKUs to Amazon, launching Irwin products in Canada (Q2) and 2 MusclePharm SKUs into ~700–800 Kroger stores starting in June, continuing 3-year dating initiative to reduce obsolescence, and shifting more advertising spend off-Amazon (Google, Meta, TikTok, CTV) to drive Amazon performance. Management expects Irwin to continue scaling (management believes $1M/month Amazon run-rate is attainable) and notes sequential monthly revenue improvement through the quarter into April/May.
